推进药物使用的绩效评估措施，以用于物质滥用治疗。
Advancing performance measures for use of medications in substance abuse treatment.
机构信息
Brandeis University, Institute for Behavioral Health, Heller School for Social Policy and Management, Waltham, MA 02454, USA.
出版信息
J Subst Abuse Treat. 2011 Jan;40(1):35-43. doi: 10.1016/j.jsat.2010.08.005. Epub 2010 Oct 8.
Abstract
Performance measures have the potential to drive high-quality health care. However, technical and policy challenges exist in developing and implementing measures to assess substance use disorder (SUD) pharmacotherapy. Of critical importance in advancing performance measures for use of SUD pharmacotherapy is the recognition that different measurement approaches may be needed in the public and private sectors and will be determined by the availability of different data collection and monitoring systems. In 2009, the Washington Circle convened a panel of nationally recognized insurers, purchasers, providers, policy makers, and researchers to address this topic. The charge of the panel was to identify opportunities and challenges in advancing use of SUD pharmacotherapy performance measures across a range of systems. This article summarizes those findings by identifying a number of critical themes related to advancing SUD pharmacotherapy performance measures, highlighting examples from the field, and recommending actions for policy makers.
摘要
绩效措施有可能推动高质量的医疗保健。然而，在制定和实施评估物质使用障碍（SUD）药物治疗的措施方面存在技术和政策挑战。在推进 SUD 药物治疗使用的绩效措施方面，至关重要的是认识到在公共和私营部门可能需要不同的测量方法，并且将取决于不同的数据收集和监测系统的可用性。2009 年，华盛顿圈召集了一批全国知名的保险公司、购买者、提供者、政策制定者和研究人员来解决这个问题。该小组的任务是确定在一系列系统中推进 SUD 药物治疗绩效措施的机会和挑战。本文通过确定与推进 SUD 药物治疗绩效措施相关的一些关键主题，突出该领域的例子，并为政策制定者推荐行动，总结了这些发现。
相似文献
1
Advancing performance measures for use of medications in substance abuse treatment.推进药物使用的绩效评估措施，以用于物质滥用治疗。
J Subst Abuse Treat. 2011 Jan;40(1):35-43. doi: 10.1016/j.jsat.2010.08.005. Epub 2010 Oct 8.
2
VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.美国退伍军人事务部（VA）住院物质使用障碍治疗项目提供者对入院前流程中促进因素和绩效障碍的看法。
Addict Sci Clin Pract. 2017 Apr 4;12(1):10. doi: 10.1186/s13722-017-0075-z.
3
4
Using administrative data to assess the process of treatment services for adolescents with substance use disorders.利用行政数据评估患有物质使用障碍青少年的治疗服务过程。
J Psychoactive Drugs. 2004 Dec;36(4):473-81. doi: 10.1080/02791072.2004.10524430.
5
Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group.为管理式医疗计划中的酒精及其他药物服务制定绩效衡量标准。华盛顿圈集团。
Jt Comm J Qual Improv. 2000 Nov;26(11):633-43. doi: 10.1016/s1070-3241(00)26054-9.
6
Substance abuse treatment engagement, completion and short-term outcomes in the Western Cape province, South Africa: Findings from the Service Quality Measures Initiative.南非西开普省物质滥用治疗的参与、完成情况及短期效果：服务质量衡量倡议的调查结果。
Drug Alcohol Depend. 2018 Apr 1;185:278-284. doi: 10.1016/j.drugalcdep.2017.12.033. Epub 2018 Feb 21.
7
HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty.物质使用障碍护理的HEDIS启动与参与质量指标：机构设置与医疗保健专业的影响
Popul Health Manag. 2009 Aug;12(4):191-6. doi: 10.1089/pop.2008.0028.
9
The primitive state of quality measures in addiction treatment and their application.成瘾治疗中质量衡量的原始状态及其应用。
Addiction. 2016 Feb;111(2):195-6. doi: 10.1111/add.13096. Epub 2015 Sep 23.
10
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标：实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
引用本文的文献
1
Characterizing intersystem and community values to enhance opioid use disorder treatments: Communities That Heal intervention in New York.刻画系统间和社区价值观以加强阿片类药物使用障碍治疗：纽约的“治愈社区”干预措施
Int J Drug Policy. 2025 Jul 16;143:104922. doi: 10.1016/j.drugpo.2025.104922.
2
Predictors of initiation of and retention on medications for alcohol use disorder among people living with and without HIV.在 HIV 感染者和非感染者中，预测开始使用和维持使用治疗酒精使用障碍的药物的因素。
J Subst Abuse Treat. 2020 Feb;109:14-22. doi: 10.1016/j.jsat.2019.11.002. Epub 2019 Nov 6.
3
Developing an opioid use disorder treatment cascade: A review of quality measures.开发阿片类药物使用障碍治疗阶梯：质量措施综述。
J Subst Abuse Treat. 2018 Aug;91:57-68. doi: 10.1016/j.jsat.2018.06.001. Epub 2018 Jun 2.
4
Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care.为美国成瘾医学协会的护理标准确定并进行质量措施的试点测试。
J Addict Med. 2016 May-Jun;10(3):148-55. doi: 10.1097/ADM.0000000000000203.
5
The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care.在初级保健中对物质依赖实施慢性护理管理后开具成瘾药物的情况。
J Subst Abuse Treat. 2015 May;52:17-23. doi: 10.1016/j.jsat.2014.11.008. Epub 2014 Dec 2.
6
Essential Ingredients for Successful Redesign of Addiction Treatment.成瘾治疗成功重新设计的关键要素。
Bridge (Kans City). 2012;2(2).
7
The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.在公共资助的物质使用障碍治疗项目中采用药物治疗的转变：组织结构、文化和资源。
J Stud Alcohol Drugs. 2014 May;75(3):476-85. doi: 10.15288/jsad.2014.75.476.
8
Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration.在退伍军人健康管理局中开具托吡酯处方以治疗酒精使用障碍。
Addict Sci Clin Pract. 2013 Jul 8;8(1):12. doi: 10.1186/1940-0640-8-12.
9
Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.评估成瘾性药物治疗应用中的绩效测量的可行性。
J Subst Abuse Treat. 2013 Jul;45(1):11-8. doi: 10.1016/j.jsat.2013.01.004. Epub 2013 Mar 13.
10
Performance measures for substance use disorders--what research is needed?物质使用障碍的绩效评估指标——需要哪些研究？
Addict Sci Clin Pract. 2012 Sep 11;7(1):18. doi: 10.1186/1940-0640-7-18.
本文引用的文献
1
Psychiatrist characteristics that influence use of buprenorphine medication-assisted treatment.影响使用丁丙诺啡药物辅助治疗的精神科医生特征。
J Addict Med. 2010 Dec;4(4):197-203. doi: 10.1097/ADM.0b013e3181c816f3.
2
Lessons from five states: public sector use of the Washington Circle performance measures.五个州的经验教训：公共部门对华盛顿圈绩效措施的使用。
J Subst Abuse Treat. 2011 Apr;40(3):241-54. doi: 10.1016/j.jsat.2010.11.008. Epub 2011 Jan 22.
3
Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.退伍军人事务部的酒精使用障碍药物治疗。
Psychiatr Serv. 2010 Apr;61(4):392-8. doi: 10.1176/ps.2010.61.4.392.
4
Launching HITECH.启动《健康信息技术经济与临床健康法案》（或：启动医疗信息技术促进经济和临床健康计划） （注：HITECH一般指Health Information Technology for Economic and Clinical Health，具体含义需结合上下文确定）
N Engl J Med. 2010 Feb 4;362(5):382-5. doi: 10.1056/NEJMp0912825. Epub 2009 Dec 30.
5
Developing and validating process measures of health care quality: an application to alcohol use disorder treatment.制定和验证医疗质量的过程指标：在酒精使用障碍治疗中的应用
Med Care. 2009 Dec;47(12):1244-50. doi: 10.1097/MLR.0b013e3181b58882.
6
Comparison of costs and utilization among buprenorphine and methadone patients.丁丙诺啡和美沙酮患者的成本与使用情况比较。
Addiction. 2009 Jun;104(6):982-92. doi: 10.1111/j.1360-0443.2009.02539.x.
7
Performance monitoring of substance use disorder interventions in the Veterans Health Administration.退伍军人健康管理局中物质使用障碍干预措施的绩效监测
Am J Drug Alcohol Abuse. 2009;35(3):123-7. doi: 10.1080/00952990802707042.
8
Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure.衡量物质使用障碍治疗的质量：评估退伍军人事务部连续护理绩效指标的有效性。
J Subst Abuse Treat. 2009 Apr;36(3):294-305. doi: 10.1016/j.jsat.2008.05.011. Epub 2008 Oct 5.
9
Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.酒精和阿片类药物依赖药物：处方趋势，总体情况及按医生专业分类的情况。
Drug Alcohol Depend. 2009 Jan 1;99(1-3):345-9. doi: 10.1016/j.drugalcdep.2008.07.018. Epub 2008 Sep 25.
10
Adapting Washington Circle performance measures for public sector substance abuse treatment systems.调整华盛顿圈针对公共部门药物滥用治疗系统的绩效衡量标准。
J Subst Abuse Treat. 2009 Apr;36(3):265-77. doi: 10.1016/j.jsat.2008.06.008. Epub 2008 Aug 21.
Zotero 插件